{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T21:18:46Z","timestamp":1717017526116},"reference-count":37,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2007,11,9]],"date-time":"2007-11-09T00:00:00Z","timestamp":1194566400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Deutsche Derma Gesell"],"published-print":{"date-parts":[[2008,2]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:italic>Background:<\/jats:italic>Benefit assessment of drugs and medical products has become a legally established feature of medical research. A standardized assessment of benefits using scientifically sound and valid methods is essential.<\/jats:p><jats:p><jats:italic>Objective:<\/jats:italic>Development, validation and practical evaluation of an instrument to record patient benefit in treatment of acne.<\/jats:p><jats:p><jats:italic>Patients and Methods:<\/jats:italic>In open interviews with n = 50 patients, possible benefits of the therapy from the patients' point of view were recorded. The item pool thus generated was reviewed by a panel of dermatologists, psychologists and patients and transferred to a 23\u2010item questionnaire. This is used prior to therapy to assess patients' desired benefits and after therapy to record the perceived benefits. The therapy goals and the resulting benefits are then used to generate a weighted \u2018Patient Benefit Index\u2019 (PBI). The procedure has been tested for its validity and feasibility in n = 923 patients with acne.<\/jats:p><jats:p><jats:italic>Results:<\/jats:italic>Patients accepted the instrument and deemed it to be easily understandable. Additionally, the method proved itself to be internally consistent, constructively valid and sensitive to changes.<\/jats:p><jats:p><jats:italic>Conclusions:<\/jats:italic>The Patient Benefit Index (PBI) is a valid and highly accepted practical instrument for recording patient benefit. The PBI permits an individualized, patient\u2010weighted assessment of the benefits of acne therapy.<\/jats:p>","DOI":"10.1111\/j.1610-0387.2007.06540.x","type":"journal-article","created":{"date-parts":[[2007,11,9]],"date-time":"2007-11-09T08:43:21Z","timestamp":1194597801000},"page":"113-120","source":"Crossref","is-referenced-by-count":18,"title":["Development and validation of a new instrument for the assessment of patient\u2010defined benefit in the treatment of acne"],"prefix":"10.1111","volume":"6","author":[{"given":"Matthias","family":"Augustin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Reich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ines","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ina","family":"Zschocke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan Jeff","family":"Rustenbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,11,27]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.134.4.454"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00435978"},{"issue":"45","key":"e_1_2_7_4_2","first-page":"35","article-title":"Standard patient assessed quality of life instruments can be used to measure the benefits of acne treatment","volume":"133","author":"Mallon E","year":"1995","journal-title":"Br J Dermatol"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-199406020-00003"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.3109\/09546639309082163"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1989.tb00930.x"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2004-813336"},{"key":"e_1_2_7_9_2","unstructured":"ZentnerA BusseR.Kriterien der Nutzenbewertung von Arzneimitteln im internationalen Vergleich. HTA\u2010Bericht DIMDI2005."},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2006-941734"},{"key":"e_1_2_7_11_2","volume-title":"Methoden. Version 2.0 vom 19.12.2006","author":"Bastian H","year":"2007"},{"key":"e_1_2_7_12_2","first-page":"16998","article-title":"Verfahrensordnung vom 20.09.2005","volume":"242","author":"Gemeinsamer Bundesausschuss","year":"2005","journal-title":"Bundesanzeiger"},{"key":"e_1_2_7_13_2","first-page":"3613","article-title":"Gesetz zur St\u00e4rkung des Wettbewerbs in der gesetzlichen Krankenversicherung vom 26.03.2007","volume":"66","year":"2007","journal-title":"Bundesanzeiger"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00105-005-0898-5"},{"key":"e_1_2_7_15_2","first-page":"25","article-title":"Nutzenbewertung der ambulanten und station\u00e4ren VAC\u2010Therapie aus Patientensicht: Multizenterstudie mit Patientenrele\u2010vanten Endpunkten","volume":"148","author":"Augustin M","year":"2006","journal-title":"MMW-Fortschr. Med. Originalien"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2004-828295"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2003-41646"},{"key":"e_1_2_7_18_2","first-page":"247","article-title":"Empfehlungen zur Durchf\u00fchrung von Anwendungs\u2010beobachtungen","volume":"28","author":"Victor N","year":"1997","journal-title":"Informatik, Biometrie und Epidemiologie in Medizin und Biologie"},{"key":"e_1_2_7_19_2","first-page":"802","article-title":"Erfassung von Le\u2010bensqualit\u00e4t in der Dermatologie (Leit\u2010linie)","volume":"9","author":"Augustin M","year":"2004","journal-title":"JDDG"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1992.tb02521.x"},{"key":"e_1_2_7_21_2","volume-title":"Measuring disease: a review of disease\u2010specific quality of life measurement scales","author":"Bowling A","year":"1995"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/hec.4730040402"},{"key":"e_1_2_7_23_2","first-page":"487","volume-title":"Quality of Life and Pharmacoeconomics in Clinical Trials","author":"Brock D","year":"1996"},{"key":"e_1_2_7_24_2","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780192631770.001.0001","volume-title":"Economic Evaluation in Health Care","author":"Drummond M","year":"2001"},{"key":"e_1_2_7_25_2","first-page":"85","volume-title":"Quality of Life and Pharma\u2010coeconomics in Clinical Trials","author":"Feeny DH","year":"1996"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(87)90069-5"},{"key":"e_1_2_7_27_2","volume-title":"Testaufbau und Testanalyse. 5. Auflage","author":"Lienert G","year":"1994"},{"key":"e_1_2_7_28_2","volume-title":"Measuring Health: a Practical Approach","author":"Smith GT","year":"1988"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.3109\/09638288309166938"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.5014\/ajot.44.6.519"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1177\/000841740206900204"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1191\/0269215502cr554oa"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1053\/apmr.2002.32636"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(03)00132-X"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1977.01770200061005"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/28.3.275"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.7748\/ns.12.42.35.s50"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1023\/B:MHSR.0000036488.12833.6e"}],"container-title":["JDDG: Journal der Deutschen Dermatologischen Gesellschaft"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1610-0387.2007.06540.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1610-0387.2007.06540.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,18]],"date-time":"2024-02-18T23:01:13Z","timestamp":1708297273000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1610-0387.2007.06540.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11,27]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["10.1111\/j.1610-0387.2007.06540.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1610-0387.2007.06540.x","archive":["Portico"],"relation":{},"ISSN":["1610-0379","1610-0387"],"issn-type":[{"value":"1610-0379","type":"print"},{"value":"1610-0387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11,27]]}}}